Insider Trading Activity Zimmer Biomet Holdings Inc (NYSE:ZBH) – VP Sold 20,826 shares of Stock

Insider Trading Activity For Zimmer Biomet Holdings Inc (NYSE:ZBH)

Chad F. Phipps , VP of Zimmer Biomet Holdings Inc (NYSE:ZBH) reportedly Sold 20,826 shares of the company’s stock at an average price of 115.95 for a total transaction amount of $2,414,774.70 SEC Form

Insider Trading History For Zimmer Biomet Holdings Inc (NYSE:ZBH)

  • On 2/4/2013 Jeffery A Mccaulley, Insider, sold 12,000 with an average share price of $73.60 per share and the total transaction amounting to $883,200.00.
  • On 2/4/2013 Derek M Davis, CAO, sold 21,864 with an average share price of $72.53 per share and the total transaction amounting to $1,585,795.92.
  • On 4/30/2013 Jeffery A Mccaulley, Insider, sold 10,000 with an average share price of $76.08 per share and the total transaction amounting to $760,800.00.
  • On 4/30/2013 James T Crines, CFO, sold 25,000 with an average share price of $76.08 per share and the total transaction amounting to $1,902,000.00.
  • On 5/8/2013 Chad F Phipps, VP, sold 5,000 with an average share price of $77.26 per share and the total transaction amounting to $386,300.00.
  • On 7/19/2013 Chad F Phipps, VP, sold 6,000 with an average share price of $83.00 per share and the total transaction amounting to $498,000.00.
  • On 7/29/2013 Jeffery A Mccaulley, Insider, sold 112,255 with an average share price of $83.40 per share and the total transaction amounting to $9,362,067.00.
  • Analyst Ratings History For Zimmer Biomet Holdings Inc (NYSE:ZBH)

    • On 3/17/2016 Nomura Initiated Coverage of rating Buy with a price target of $123.00
    • On 5/16/2016 Sterne Agee CRT Reiterated Rating Buy
    • On 7/29/2016 JMP Securities Boost Price Target of rating Market Outperform with a price target of $131.00 to $145.00
    • On 8/23/2016 Barclays Boost Price Target of rating Overweight with a price target of $140.00 to $145.00
    • On 9/22/2016 Argus Reiterated Rating Buy with a price target of $140.00
    • On 11/8/2016 Northcoast Research Downgraded rating Buy to Neutral
    • On 1/5/2017 JPMorgan Chase & Co. Set Price Target of rating Buy with a price target of $134.00

    Dividend Information For Zimmer Biomet Holdings Inc (NYSE:ZBH)
    Zimmer Biomet Holdings Inc (NYSE:ZBH) pays an annual dividend of $0.96 with a yield of 0.82% and an average dividend growth of 0.00% (3 Year Average).

    Dividend History For Zimmer Biomet Holdings Inc (NYSE:ZBH)

  • On 12/14/2012 Zimmer Biomet Holdings Inc announced a quarterly dividend of $0.18 1.06% with an ex dividend date of 12/24/2012 which will be payable on 1/25/2013.
  • On 3/8/2013 Zimmer Biomet Holdings Inc announced a quarterly dividend of $0.20 1.06% with an ex dividend date of 3/26/2013 which will be payable on 4/26/2013.
  • On 6/14/2013 Zimmer Biomet Holdings Inc announced a quarterly dividend of $0.20 1.03% with an ex dividend date of 6/26/2013 which will be payable on 7/26/2013.
  • On 9/9/2013 Zimmer Biomet Holdings Inc announced a quarterly dividend of $0.20 0.99% with an ex dividend date of 9/25/2013 which will be payable on 10/25/2013.
  • On 12/16/2013 Zimmer Biomet Holdings Inc announced a quarterly dividend of $0.20 0.88% with an ex dividend date of 12/24/2013 which will be payable on 1/31/2014.
  • On 3/5/2014 Zimmer Biomet Holdings Inc announced a quarterly dividend of $0.22 0.9% with an ex dividend date of 3/26/2014 which will be payable on 4/25/2014.
  • On 5/23/2014 Zimmer Biomet Holdings Inc announced a quarterly dividend of $0.22 0.86% with an ex dividend date of 6/25/2014 which will be payable on 7/25/2014.
  • Recent Trading Activity for Zimmer Biomet Holdings Inc (NYSE:ZBH)
    Shares of Zimmer Biomet Holdings Inc closed the previous trading session at 25.18 +0.00 0.00% with 115.2300033569336 shares trading hands.

    An ad to help with our costs